Tamoxifen-Induced Anorexia Is Associated With Fatty Acid Synthase Inhibition

[R.B.]

More intriguing links between BC mediators and fatty acid synthesys FAS.

Tamoxifen appears to mediate in FAS.


RB


ABSTRACT

http://www.ncbi.nlm.nih.gov/entrez/q...=pubmed_docsum

1: Diabetes. 2006 May;55(5):1327-1336. Related Articles, Links
Click here to read
Tamoxifen-Induced Anorexia Is Associated With Fatty Acid Synthase Inhibition in the Ventromedial Nucleus of the Hypothalamus and Accumulation of Malonyl-CoA.

Lopez M, Lelliott CJ, Tovar S, Kimber W, Gallego R, Virtue S, Blount M, Vazquez MJ, Finer N, Powles TJ, O'rahilly S, Saha AK, Dieguez C, Vidal-Puig AJ.

Department of Clinical Biochemistry, University of Cambridge, Addenbrooke's Hospital, Hills Road Cambridge, CB2 2QR, U.K. ajv22@cam.ac.uk.

Fatty acid metabolism in the hypothalamus has recently been shown to regulate feeding. The selective estrogen receptor modulator tamoxifen (TMX) exerts a potent anorectic effect. Here, we show that the anorectic effect of TMX is associated with the accumulation of malonyl-CoA in the hypothalamus and inhibition of fatty acid synthase (FAS) expression specifically in the ventromedial nucleus of the hypothalamus (VMN). Furthermore, we demonstrate that FAS mRNA expression is physiologically regulated by fasting and refeeding in the VMN but not in other hypothalamic nuclei. Thus, the VMN appears to be the hypothalamic site where regulation of FAS and feeding converge. Supporting the potential clinical relevance of these observations, reanalysis of a primary breast cancer prevention study showed that obese women treated with TMX gained significantly less body weight over a 6-year period than obese women given placebo. The finding that TMX can modulate appetite through alterations in FAS expression and malonyl-CoA levels suggests a link between hypothalamic sex steroid receptors, fatty acid metabolism, and feeding behavior.

PMID: 16644689 [PubMed - as supplied by publisher]